Live feed02:30:00·6mPRReleasevia QuantisnowEnhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast CancerByQuantisnow·Wall Street's wire, on your screen.AZN· AstraZeneca PLCHealth Care
